Abiraterone for treating newly diagnosed high-risk hormone-sensitive metastatic prostate cancer

Final draft guidance: 2

Final appraisal document (PDF 319 KB)

Public committee slides (PDF 1.12 MB)

Draft guidance: 2

Appraisal consultation document (PDF version) (PDF 349 KB)

Appraisal consultation document (online commenting)

Committee papers (PDF 583 KB)

BUG : Appeal letter (MSWord 226 KB)

Janssen : Appeal letter (MSWord 59 KB)

TPC/PCUK : Appeal letter (MSWord 1.17 MB)

BUG : Scrutiny letter (MSWord 57 KB)

Janssen : Scrutiny letter (MSWord 58 KB)

TPC/PCUK : Scrutiny letter (MSWord 56 KB)

BUG : Response to scrutiny letter (MSWord 119 KB)

BUG/NHSE : Response to scrutiny letter (MSWord 173 KB)

Janssen : Response to scrutiny letter (MSWord 624 KB)

BUG : Final scrutiny letter (MSWord 61 KB)

Janssen : Final scrutiny letter (MSWord 59 KB)

Final draft guidance: 1

Final appraisal document (PDF 290 KB)

Committee papers (PDF 3.98 MB)

Public committee slides (PDF 1.48 MB)

Draft guidance: 1

Appraisal consultation document (PDF 364 KB)

Committee papers (PDF 3.99 MB)

Final scope (PDF 85 KB)

NICE's response to comments on the draft scope and provisional matrix (MSWord 26 KB)

Equality impact assessment (Scoping) (PDF 173 KB)